Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued

2.2 / 5 stars · 23/52 Roast Me

Definium Therapeutics, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued

Definium Therapeutics, Inc. (DFTX) had Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued of $0 as of 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Balance Sheet › Liabilities

us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued · last filed 2026-02-26

  • 2025-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
  • 2024-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
Period endUnrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
2025-12-31$0.00
10-K · filed 2026-02-26
2024-12-31$0.00
10-K · filed 2026-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B